Apalutanide for the treatment of non-metastatic castration-resistant prostate cancer in subjects with severe hepatic impairment

LT4054572TActive Publication Date: 2026-09-10ARAGON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
LT4054572P0
Authority / Receiving Office
LT · LT
Patent Type
Patents
Current Assignee / Owner
Priority Date
2020-11-04
Filing Date
2020-11-04
Publication Date
2026-09-10
Estimated Expiration
2040-11-04
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.